Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Juel Group p.l.c. – New Bond Issue

Juel Group p.l.c. (the “Issuer”), is pleased to announce the issue of €32,000,000 Secured bonds at 5.5% at a nominal value of €100 per bond, redeemable in 2035 (the “Bond Issue”), following approval by the Listing Authority.

This bond issue will be subject to a minimum of €2,000, and will be issued at par. The interest rate of 5.5 per cent will be paid annually on 27 June as from 27 June 2024 (the first interest payment date).

The use of the bond proceeds will consist of:

The amount of €9,743,300 will not be received by the Issuer as net bond proceeds. An amount of €9,743,300 in nominal value of Secured Bonds shall be issued and allotted to MZI, or such persons as it may direct, in repayment of the Bond Advance Facility Amount and the premium outstanding thereunder.

The proceeds from the Bond Issue, which net of Bond Issue expenses are expected to amount to approximately €21,616,700 shall be used by the Issuer for the following purposes, in the amounts and order of priority set out below:

a) approximately €8 million shall be used to finance outstanding principal and interest under a bank loan granted by Bank of Valletta p.l.c. to the Issuer for the purpose of the acquisition of the Sans Souci Site by Juel Hospitality; and

b) approximately €13,616,700 shall be used to finance costs equired to partly construct and develop the Hotel in accordance with approved planning permits. This amount shall be released by the Security Trustee in a corresponding value contained in an architect’s confirmation of value of works.

Full details about this Bond Issue are set out in the Prospectus dated 6 June 2022 which can be found here.

MeDirect will be accepting applications from anyone, who is interested. All applications must be received by not later 27th June 2022. In the event of over-subscription, the Issuer reserves the right to close the Offer Period before this date.

If you are interested in applying, please send us a Secure Mail or contact your Relationship Manager.

For further information, please call us on (+356) 2557 4400 or send an email to customerservice@medirect.com.mt.


The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns.

Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.

MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material is intended only for the use of the recipient and shall not be reproduced in any way, whether in whole or in part, by the recipient. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Liontrust Quarterly Update
All News

Market Update by Liontrust – Q1 2024

Q1 2024 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.

Higher bar for U.S. earnings to deliver
All News

BlackRock Commentary: Higher bar for U.S. earnings to deliver

In 2024, we witnessed two distinct narratives unfold. Initially, cooling inflation and robust corporate earnings supported a positive risk appetite.
However, later in the year, resurging inflation emerged, disrupting market sentiment. While BlackRock maintain an overweight position in U.S. stocks, they remain prepared to adapt to changing market conditions.

Earnings growth not just about tech
All News

BlackRock Commentary: Earnings growth not just about tech

Robust U.S. economic expansion and corporate earnings have bolstered risk sentiment, propelling stocks to record levels, despite notable increases in bond yields. BlackRock anticipates that earnings performance will be crucial in meeting elevated market expectations, particularly following recent data revealing persistent inflation concerns that unnerved investors.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.